New-onset vitiligo during treatment with golimumab

Ann Dermatol Venereol. 2023 Sep;150(3):230-231. doi: 10.1016/j.annder.2023.03.001. Epub 2023 Apr 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Humans
  • Hypopigmentation*
  • Vitiligo* / chemically induced

Substances

  • golimumab
  • Antibodies, Monoclonal